Rafael Holdings RFL
NYSE RFL
$1.28 +0.00 (+0.00%)
As of: Oct 23, 2026 · 3:59 PM EDT

Rafael Holdings (RFL) Cash & Current Investments (2017 - 2026)

Updated

Rafael Holdings (RFL) posted Cash & Current Investments of $30.5 million for fiscal Q3 2026 (quarter ended Apr 30, 2026), down 19.6% from $37.94 million a year earlier and down 19.3% from the prior quarter.

Analysis

Rafael Holdings (RFL) Cash & Current Investments (2017 - 2026) Analysis & Trends

At the end of FY2025 (ended Jul 31, 2025), Rafael Holdings' Cash & Current Investments came in at $52.77 million, down 20.0% from FY2024.

  • Annual Cash & Current Investments shows a five-year compound annual growth rate of 53.4% (FY2020 to FY2025).
  • In prior fiscal years, Rafael Holdings' Cash & Current Investments was $65.94 million in FY2024 (-16.8%), $79.21 million in FY2023 (+25.3%), $63.24 million in FY2022 (+391.9%) and $12.85 million in FY2021 (+107.1%).
  • The fiscal Q3 2026 figure stands as the lowest quarterly Cash & Current Investments since fiscal Q1 2024.
  • On a year-over-year basis, Cash & Current Investments has declined in each of the last six quarters, with growth averaging 15.1% over the last eight quarters.
  • The strongest year-over-year quarter for Cash & Current Investments in the past five years was fiscal Q1 2022, with growth of 901.1%; the weakest was fiscal Q1 2024, with a decline of 85.8%.
  • According to Business Quant data, Cash & Current Investments for the three prior fiscal quarters was $37.8 million (Q2 2026), $45.54 million (Q1 2026) and $52.77 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Rafael Holdings 67.11 Mn -99.50 Mn 163,000.00 30.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 30.50 Mn
Jan 31, 2026 37.80 Mn
Oct 31, 2025 45.54 Mn
Jul 31, 2025 52.77 Mn
Apr 30, 2025 37.94 Mn
Jan 31, 2025 48.32 Mn
Oct 31, 2024 54.34 Mn
Jul 31, 2024 65.94 Mn
Apr 30, 2024 105.14 Mn
Jan 31, 2024 71.74 Mn
Oct 31, 2023 13.20 Mn
Jul 31, 2023 79.21 Mn
Apr 30, 2023 82.40 Mn
Jan 31, 2023 88.87 Mn
Oct 31, 2022 93.19 Mn
Jul 31, 2022 63.24 Mn
Apr 30, 2022 30.41 Mn
Oct 31, 2021 72.39 Mn
Jul 31, 2021 12.85 Mn
Apr 30, 2021 4.68 Mn
API Access

Rafael Holdings Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=RFL&period=max&api_key=YOUR_API_KEY